The gene encoding the African swine fever virus protein of Mr 11500, present 
Introduction
African swine fever virus (ASFV) is an icosahedral virus with lipid envelopes and dsDNA of about 170 kbp (for reviews, see Vifiuela, 1985 Vifiuela, , 1987 Costa, 1990; Dixon et al., 1990) . The virus is the causative agent of a highly contagious and frequently fatal disease of domestic pigs. A peculiar aspect of the ASFV infection is the absence of neutralizing antibodies in recovered or chronically infected pigs or in ASFV-resistant animal species inoculated with the virus; therefore the use of conventional vaccines is not suitable (De Boer, 1967) . Twodimensional gel electrophoresis analyses of lysates of ASFV-infected cells have demonstrated the presence of about 100 virus-induced polypeptides, with M r values from 10000 to 220000 (Esteves et al., 1986; Santar6n & Vifiuela, 1986) . ASFV particles show a complex morphology and contain more than 30 proteins in the M r range of 10000 to 15000 (Carrascosa et al., 1984;  The nucleotide sequence data reported in this paper have been submitted to the GenBank, EMBL and DDBJ databases and assigned the accession number L16901. Carrascosa et aI., 1985) , but lack glycoproteins (Del Val et al., 1986) . Some of these proteins are enzymes involved in the synthesis and modification of early virus mRNA (Kuznar et al., 1980; Salas et al., 1981) . Several proteins present in the virus particle, p34, p37 and p150, originate by proteolytic processing at a specific sequence, Gly-Gly-X, from a precursor of higher M r (L6pez- Otin et al., 1989; Sim6n-Mateo et al., 1993) . The number of ASFV genes known to encode virion proteins is limited, and the nucleotide sequences of only the genes encoding proteins p37, p72, p22 and p12 have been reported so far (L6pez-Otin et al., 1988 (L6pez-Otin et al., , 1990 Camacho & Vifiuela, 1991; A!cami et al., 1992) .
A systematic identification of the ASFV genes encoding virion proteins was necessary to characterize properly the protein products, in order to identify those viral components which may constitute targets for neutralizing antibodies. In this paper we describe the use of a serum raised against proteins of M r 12000 to 13 000 and a plasmid expression library to identify ASFV genes encoding virion proteins of low M r. We report the mapping and sequence of an ASFV gene encoding a protein of 11500 M r. The initial characterization and localization of the protein in infected cells are also presented.
virus strain BA71V has been described elsewhere (Garcia-Barreno et al., 1986) .
Mapping of the gene.
A rat serum raised against virion proteins of Mr 12000 to 13000, isolated after SDS-PAGE (Carrascosa et al., 1991) , was used to screen an ASFV expression library in which viral proteins are synthesized as products fused to fl-galactosidase (F. Almazfin, J. M. Almendral, S. Baars & E. Vifiuela, unpublished results). DNA from recombinant pEX clones selected with antibodies was digested with BamHI and the inserts were labelled with [c¢-~2P]dATP by nick translation according to standard procedures. The a~P-labelled probes were used to group the different clones selected with the antiserum and to map the genes in the virus genome by dot blot hybridization to cloned restriction fragments covering the complete length of the viral genome (Ley et al., 1984) . Subsequent Southern blot hybridization of specific labelled oligonucleotide probes was used to localize more precisely the position of the genes in the viral genome. DNA manipulations were performed according to standard procedures (Sambrook et al., 1989) .
DNA sequencing. This was performed on ss-and dsDNA templates by the dideoxynucleotide chain termination method (Sanger et al., 1977) . The SalI B EcoRI A fragment cloned into M13mpl8, the EcoRI KpnI fragment of 3 kbp of the 5' end of the EcoRI F fragment, cloned into M13mpl8 and M13mpl9, and the HindIII D fragment cloned into pUC18 were used as templates. The positions of these fragments in the BA71V genome are shown in Fig. 1 (Ley et al., 1984) . Escherichia coli JM109 was used as the host for plasmids and bacteriophage M 13. Computer analysis of DNA and protein sequences was performed with the software package of the University of Wisconsin Genetics Computer Group (Devereux et al., 1984) .
Plasmid constructions. We first constructed a pUC18 derivative (Vieira & Messing, 1982) that contained the entire open reading frame (ORF) A137R, lacking most of the flanking regions, and with convenient restriction sites at each end. Plasmid pUCHD, containing the HindIII D fragment of the BA71V genome, was digested with Fnu4HI and AvaII, which cut at 64bp upstream and 108 bp downstream of the ORF. A 570 bp Fnu4HI-AvaII fragment was filled with the Klenow fragment and cloned into SmaI-cut pUC18. The plasmid in which the 31 end of ORF A137R was near the BamHI site of the polylinker of pUC18 was chosen and termed pUCA137R.
The vector pET3c was used for expression ofORF A137R in E. coli using T7 RNA polymerase (Studier et al., 1990) . Plasmid pUCA137R was digested with KpnI, and the 5' flanking region was removed by Bal 31 endonuclease digestion for different times and end-repaired with the Klenow fragment. The ORF was excised from the vector by BamHI digestion and inserted into the Klenow fragment-filled NdeI and BamHI sites of pET3c. A recombinant containing the initiator ATG close to the Shin~Dalgarno sequence of pET3c, named pETA137R, was selected by hybridization with a specific oligonucleotide and the construct was confirmed by nucleotide sequencing.
Expression of the protein in E. coli. Cultures ofE. coli POP (Stanley, 1983) bearing recombinant pEX plasmids were incubated at 42 °C for 2 h to induce expression of the fl-galactosidase fusion proteins. E. coli BL21(DE3) (Studier et al., 1990) transformed with pET3c or with the recombinant plasmid pETA137R were induced for expression by the addition of IPTG and pulse-labelled for 5 min with 200 gCi/ml of [aSS]methionine (1200 Ci/mmol; Amersham) at different times after induction, in the absence or presence of rifampicin, as described (Studier et al., 1990) .
Antisera. To prepare a specific serum against the protein encoded by ORF A137R, rabbits were immunized with E. coli BL21(DE3) which had been transformed with pETA 137R, induced for 2 h with IPTG and lysed by sonication in PBS. A rabbit serum against inactivated BA71V-infected Veto cell extracts (Del Val & Vifiuela, 1987 ) and a swine serum from an animal infected with BA71V, provided by Y. Revilla, were used in immunoprecipitation experiments.
Metabolic labelling and immunopreeipitation of infected cells and purified virus.
Cultures of Vero cells were pulse-labelled at different times after infection with [3~S]methionine in methionine-free medium. Extracellular ASFV particles were purified by Percoll equilibrium centrifugation from infected cells labelled with [~S] methionine for 24 h of infection (Carrascosa et al., 1985) . Purified virus and infected cells were dissociated in 10 mM-Tris-HC1 pH 7.5, 150 mM-NaC1, 1% sodium deoxycholate, 1% NP40, 0.1% SDS and 1 mM-PMSF, and immunoprecipitated with specific antisera and Protein A Sepharose as described (Harlow & Lane, 1988) .
Analysis of proteins by eleetrophoresis.
Whole extracts or immune complexes were dissociated with 0.4 M-TribHC1 pH 6-3, 2.3 % SDS and 10 % glycerol, and analysed by SDS-PAGE in 7 to 20 % acrylamide gels as described (Laemmli, 1970) . Proteins were detected by fluorography (Bonner & Laskey, 1974) or stained with Coomassie blue.
Immunofluorescence. Vero ceils were infected at a multiplicity of 0.1 p.f.u./cell. At the indicated times, cells were fixed with methanol at -20 °C for 2 min, and incubated with rabbit serum against pETA137R-transformed E. coli and rhodamine-conjugated goat antirabbit IgG.
Results and Discussion

Mapping and sequence of ORF A137R
To identify ASFV genes encoding virion proteins of low Mr, a serum raised against virion proteins ofM r 12000 to 13 000 isolated from SDS-polyacrylamide gels was used to screen an ASFV expression library (pEX) in which viral proteins are synthesized as fusion products with flgalactosidase (F. Almazfin, J. M. Almendral, S. Baars & E. Vifiuela, unpublished results). Thirty-eight clones were selected and grouped by DNA hybridization in group A (23 clones), group B (13 clones) and group C (two clones). Representative members of each group were hybridized to a genomic library of viral DNA to localize the corresponding genes in the virus genome (Fig. 1 a) . DNA sequencing of six clones of group A showed that all of them expressed the N-terminal region of an ORF previously sequenced that encodes a precursor which gives rise, after proteolytic cleavage, to the virion protein p37 corresponding to the C-terminal region (L6pez-Otin et al., 1988) . This result suggested strongly that a low M r protein is also encoded by the 5' end of the previously reported gene. In accordance with this hypothesis, a protein of M r 14000 has been found to be derived from a large precursor that gives rise to several ASFV proteins which become incorporated into virions, including p37, after proteolytic cleavage at a Gly-Gly-X sequence (Simdn-Mateo et al., 1993) . The sequence of the two clones of group C showed that they expressed an ORF known to encode a polypeptide of approximate Mr 15 000, present in the virus particle (L. Martinez & E. Vifiuela, unpublished results). The clones of group B contained agene not sequenced previously, 40  60  80  100  120  140  160  170   ,  ,  ,  ,  j  ,  ,  , which might encode a virion protein of M r 12000 to 13 000. Southern blotting localized the gene in the 5' end EcoRI KpnI subfragment of EcoRI F, contiguous to the EcoRI A fragment (Fig. lb) . This, together with the hybridization to the EcoRI A fragment, suggested that the ORF lies in both the EcoRI A and F fragments (Fig.  lb) . Fig. 1 (c) shows the nucleotide sequence of the gene, which was determined by using the p E X r e c o m b i n a n t clones and M13 and p U C derivatives c o n t a i n i n g A S F V D N A fragments as templates. The O R F was n a m e d A137R because it initiates in the E c o R I A fragment, is predicted to encode a polypeptide of 137 amino acids, and is transcribed rightward toward the genome terminus. The O R F extends into the E c o R I F fragment a n d an E c o R I restriction site divides the gene into two parts. A r u n of seven consecutive thymidylate residues, which has been proposed to act as a transcriptional t e r m i n a t i o n signal of both early a n d late A S F V genes (Almaz~in et al., 1992 (Almaz~in et al., , 1993 , is present in the intergenic region downstream of the O R F . The gene is predicted to encode a polypeptide o f M r 16070 with an isoetectric point of 6.14. The absence of N-glycosylation sites would be in agreement with the lack of glycoproteins in A S F V particles (Del Val et al., 1986) . (Fig. 2b) . (p.i.) as a polypeptide of M r 11500, and was not detected at early times (Fig. 3 a) . The absence of synthesis in the presence of the DNA replication inhibitor cytosine arabinoside corroborated that the polypeptide encoded by ORF A137R is translated after the onset of viral DNA synthesis, and thus it belongs to the late class of viral genes. The protein was synthesized with similar kinetics in primary cultures of swine alveolar macrophages infected with BA71V (data not shown). Immunoprecipitation with the serum against virion proteins of M r 12000 to 13000 gave the same result (Fig. 3a) . The lack of recognition of the proteins of M r 14000 and 15000, identified with this antiserum in the bacterial expression library, might reflect differences in the antigenicity of these proteins when different techniques for detection with antibodies are used. In fact, these proteins have been detected in ASFV-infected cells by immunoprecipitation when other sera raised against the proteins expressed in E. coli were used (Simdn-Mateo et al., 1993; L. Martfnez & E. Vifiuela, unpublished results) . Similarly, the antiserum against virion proteins of M r 12000 to 13000 does not recognize the ASFV attachment protein p12 in virus particles . Labelling experiments with tritiated palmitic and myristic acids, under conditions described before (Aguado et al., 1991) , followed by immunoprecipitation with specific antiserum showed that the protein encoded by ORF A137R is not covalently bound to fatty acids (data not shown). The protein was detected by Western blotting (data not shown) and immunoprecipitation in highly purified preparations of extracellular virus particles (Fig. 3b) , confirming that the polypeptide is incorporated into virions. The protein, of an estimated M r of 11 500, showed an electrophoretic mobility close to, but lower than, the previously identified ASFV attachment protein p12 (Carrascosa et al., 1991 ; Alcamf et al., 1992) , present in the preparations of virus particles used as M r markers (Fig. 3 b) . Although the protein of M r 11 500 is a minor component of the purified virus preparations and can hardly be detected in the fluorograph shown in Fig. 3 (b) , the presence of a protein of this size in the virus particle was also detected in immunoprecipitations performed with rabbit and swine sera raised against ASFV proteins (Fig. 3b) . This also illustrated that the protein of M r 11500 is highly antigenic since it was immunoprecipitated more efficiently than other major virion proteins such as protein p72.
Synthesis of A137R in infected cells and presence in purified virions
IntracelIular localization of protein A137R
Immunofluorescence experiments were carried out to determine the subcellular localization of the protein encoded by ORF A137R. Fig. 4 shows that the protein localized in discrete perinuclear cytoplasmic areas after 12 h p.i. which corresponded to viral factories where virus morphogenesis occurs. This localization was con-firmed with double labelling with monoclonal antibody 19BA2 (Sanz et al., 1985) , specific for the major structural ASFV protein p72 (data not shown), and was in accordance with the protein being incorporated into virions. Later during infection, the fluorescence was distributed also as a speckled pattern throughout the cytoplasm and concentrated in areas near the cell surface which might correspond to specialized regions used for virus egress. A similar pattern has been found with antibodies against the ASFV attachment protein p12 .
Conclusions
The role of the protein encoded by ORF A137R in the ASFV infection is not known. It might be possible that the protein constitutes a structural component of the virion, in which case it would interact with other ASFV proteins and no homologue would be found in other systems. The availability of the sequence of the gene and the protein expressed in an heterologous system will be important for the elucidation of the role that A137R has in the ASFV replication cycle. For example, it will enable the construction of virus recombinants (Rodriguez et al., 1992) containing a truncated version of the gene to determine whether the protein is required for ASFV replication in tissue culture. Although the function of the protein remains to be determined, the protein could induce a neutralizing response against ASFV through an unknown mechanism. However, preliminary experiments indicate that the recombinant protein produced in E. coli does not induce rabbit antibodies able to neutralize the ASFV infectivity in a neutralization assay in the absence or presence of complement (A. Alcami, A. Angulo & E. Vifiuela, unpublished results) .
In summary, we report the sequence of an ASFV gene encoding a virion protein of M r 11 500. The protein is synthesized after the onset of viral DNA replication and localizes in virus factories in the cytoplasm of infected cells.
